Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · IEX Real-Time Price · USD
1.790
-0.080 (-4.28%)
At close: Jul 2, 2024, 4:00 PM
1.761
-0.029 (-1.62%)
After-hours: Jul 2, 2024, 4:28 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.92 million as of July 2, 2024. Its market cap has decreased by -53.60% in one year.
Market Cap
2.92M
Enterprise Value
-11.63M
1-Year Change
-53.60%
Ranking
Category
Stock Price
$1.79
Market Cap Chart
Since October 8, 2020, Revelation Biosciences's market cap has decreased from $93.30M to $2.92M, a decrease of -96.87%. That is a compound annual growth rate of -60.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 3.10M | -3.13% |
| Dec 29, 2023 | 3.20M | -28.89% |
| Dec 30, 2022 | 4.50M | -96.90% |
| Dec 31, 2021 | 145.20M | 55.46% |
| Dec 31, 2020 | 93.40M | 0.11% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 3.29M |
| Petros Pharmaceuticals | 3.20M |
| INVO Bioscience | 3.20M |
| Phio Pharmaceuticals | 3.18M |
| ZyVersa Therapeutics | 3.14M |
| Alzamend Neuro | 3.11M |
| 60 Degrees Pharmaceuticals | 3.09M |
| Sintx Technologies | 2.94M |